N. Janiczek

Clinical Pharmacokinetics · 2010

A researcher in the Science corpus: 1 paper; trusts 0 researchers and is trusted by 0 researchers here, as inferred from the citation graph.

Papers from N. Janiczek's perspective

Ordered by how strongly the researchers N. Janiczek trusts endorse each paper. Same corpus, a different order for every researcher.

  1. The mechanisms of action of gabapentin and pregabalin. (Current opinion in pharmacology (Print))
  2. The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trial (The Lancet)
  3. A high resolution HLA and SNP haplotype map for disease association studies in the extended human MHC (Nature Genetics)
  4. Association between presence of HLA-B*5701, HLA-DR7, and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir. (The Lancet)
  5. Variability in the clinical pattern of cutaneous side‐effects of drugs with systemic symptoms: does a DRESS syndrome really exist? (British Journal of Dermatology)
  6. HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin (Nature Genetics)
  7. MaCH: Using Sequence and Genotype Data to Estimate Haplotypes and Unobserved Genotypes (Genetic Epidemiology)
  8. Genetic variations in HLA-B region and hypersensitivity reactions to abacavir. (The Lancet)
  9. The anatomy of memory: an interactive overview of the parahippocampal–hippocampal network
  10. Association of multidrug resistance in epilepsy with a polymorphism in the drug-transporter gene ABCB1. (New England Journal of Medicine)

Their papers